A case of late presentation of darunavir-related cholestatic hepatitis
- 5 February 2019
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 30 (6), 620-622
- https://doi.org/10.1177/0956462419826723
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 5 references indexed in Scilit:
- Drug HepatotoxicityClinics in Liver Disease, 2016
- Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1–Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation CohortHIV Research & Clinical Practice, 2014
- Hepatoxicity of new antiretrovirals: A systematic reviewClinics and Research in Hepatology and Gastroenterology, 2013
- Toxicity of HIV protease inhibitors: clinical considerationsCurrent Opinion in HIV and AIDS, 2008
- Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsThe Lancet, 2007